5AM Ventures VII, L.P.

10% OwnerSkye Bioscience, Inc. (SKYE) · full profile →Form 4 · filed Sep 13, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.8M
Net Open-Market Flow
-$1.8M
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 13, 2024Sell(S)12K$6.06$71K8.2M
Sep 13, 2024Sell(S)2K$6.06$12K1.7M
Sep 13, 2024Sell(S)79$6.06$47966K
Sep 11, 2024Sell(S)1K$6.60$10K66K
Sep 11, 2024Sell(S)215K$6.60$1.4M8.2M
Sep 11, 2024Sell(S)37K$6.60$241K1.7M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-023399) within minutes of acceptance. Every field above traces to the original document. Verify it directly: